PSAT1 and prostate carcinoma: Additionally, Van dem Bend et al. demonstrated that LNCaP cells (androgen-responsive cell line that originates from a lymph node metastasis from a prostate carcinoma) that overexpress TRPS1 show a reduction in the expression of androgen-induced PSA in those cells [39].